S&P 5007,659▼ 1.09%Nasdaq26,140▼ 2.15%Dow Jones52,002▼ 0.34%Nasdaq 10029,188▼ 2.50%VIX19.99▲ 21.45%US Dollar101.84▼ 0.21%Gold (GLD)382.01▼ 0.18%Oil (USO)161.76▲ 2.83%
Home › AMP › Research report
← AMP page
XStocksXray
Research report · 16 October 2026

Ameriprise Financial Inc (AMP)

Financials · Asset Management & Custody Banks · US stock · price as of 16 Oct 2026

Key indicators

Price$500.80
52-week range$419.52 – $572.56
Market cap$46.5B
P/E (trailing)12.2×
Dividend yield1.3%
Revenue (last 12 months)$19.8B
Revenue growth (3y a year)9.7%
Price / book7.3×
Return on equity62.0%

Fair value

Blended fair value$135.22 book-value models
Versus priceOvervalued−73% to fair value
Excess-return model (banks, insurers)$104.36
Price / book vs return on equity$181.51
Model uncertaintyMedium

X-Ray Score

60/ 100 · Medium confidence · ahead of 80% of sector peers
Valuation56
Growth55
Profitability60
Financial health73
Dividends57

Five-year price chart navy: price · brown: 200-day average · blue band: fair value range

109231353475597Fair value $1352021-102023-012024-042025-072026-10

Executive summary

Ameriprise Financial provides wealth management, asset management and insurance and annuity products. Its network of financial advisors serves individual clients with planning, investment accounts and retirement services, while its asset management arm offers funds and strategies under the Columbia Threadneedle name. The company earns fees tied to client assets and advice, plus spread and premium income from insurance and annuity products. Market levels therefore have a strong influence on its results.

Sales came to $19.8 billion in the last twelve months, having expanded at 9.7% a year across the last three years. Its operating margin came to 25.5%. The company pays a dividend, yielding 1.3%. These figures describe past results and say nothing certain about the future.

StocksXray gives Ameriprise Financial Inc an X-Ray Score of 60 out of 100 (medium confidence), ahead of 80% of the S&P 500 stocks in its sector. Its strongest lens is financial health (73) and its weakest is growth (55).

Our fair value blend is $135.22. At $500.80 the stock trades 270% above that blend, so the label is "Overvalued" with medium model uncertainty. Fair value is a range, not a price target.

stocksxray.com · page 1
XStocksXray
Ameriprise Financial Inc (AMP)

Valuation history multiples at each fiscal year-end price; the last column uses today's price and the last twelve months

FY2021FY2022FY2023FY2024FY2025Now
Price$281.49$295.49$366.38$520.61$485.60$500.80
Market cap$33.8B$33.6B$39.5B$53.6B$47.7B$46.5B
P/E9.9×10.7×15.5×15.8×13.4×12.2×
Price / book7.0×8.8×8.4×10.2×7.3×7.3×
Dividend yield–––––1.32%

Fundamentals checklist ● 2 Good · ● 3 Average · ● 1 Bad · each check graded against the sector

Risk models

Piotroski F-Score8 of 9Good

Growth

EPS growth (3y)9.4%Average
Revenue growth (3y)9.7%Average
Growth consistency100%Good

Valuation

Fair value vs price0.3×Bad

Profitability

Operating margin25.5%Average
stocksxray.com · page 2
XStocksXray
Ameriprise Financial Inc (AMP)

Financials US$ millions, from SEC filings; last column is the last twelve months

Income statementFY21FY22FY23FY24FY25LTM
Revenue13,38914,33416,09617,92618,91119,839
Net income3,4173,1492,5563,4013,5633,948
Diluted EPS ($)28.4827.7023.7133.0536.2841.19
Net margin25.5%22.0%15.9%19.0%18.8%19.9%
Balance sheetFY21FY22FY23FY24FY25LTM
Total assets177,735158,852175,191181,403190,904197,871
Cash9,5698,7558,6209,48911,15811,159
Total debt––––––
Equity4,8373,8034,7295,2286,5496,366
Dividend per share ($)––––––

Revenue and net income US$ billions: navy revenue, teal net income

FY21FY22FY23FY24FY25

Margins blue gross, teal operating, brown net

0%10%21%31%FY21FY22FY23FY24FY25

Latest quarters

Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Revenue ($M)4,4814,4904,8935,0474,8865,013
Growth vs a year earlier+3.6%+2.2%+7.3%+8.6%+9.0%+11.6%
Net income ($M)5831,0609121,0089151,113
Diluted EPS ($)5.8310.739.33–9.6811.98
stocksxray.com · page 3
XStocksXray
Ameriprise Financial Inc (AMP)

Peers in Asset Management & Custody Banks

CompanyX-Ray
AMP · Ameriprise Financial Inc60
APO · Apollo Global Management,...51
STT · State Street Corp50
BX · Blackstone Inc.49
TROW · Price T Rowe Group Inc45

Market Compass outlook for Financials: Favourable (72/100). It blends regime history, macro sensitivity, momentum and valuation.

Returns

1 week+0.1%
1 month−8.2%
3 months−4.5%
6 months+10.5%
1 year+5.4%
3 years+58.3%
5 years+93.0%

Technical summary

DailyNeutral6 bullish · 4 neutral · 6 bearish
WeeklyNeutral6 bullish · 1 neutral · 5 bearish
MonthlyStrongly bullish7 bullish · 1 neutral · 0 bearish
50-day / 200-day average$533.55 / $491.29
52-week low / high$419.52 / $572.56
Classic pivot, support and resistanceS2 489.94 · S1 495.37 · P – · R1 507.87 · R2 514.94

Recent dividends

Ex-dividend dateAmount per share
3 Aug 2026$1.7000
4 May 2026$1.7000
9 Feb 2026$1.6000
10 Nov 2025$1.6000
4 Aug 2025$1.6000
5 May 2025$1.6000
stocksxray.com · page 4
XStocksXray
Ameriprise Financial Inc (AMP)

Strengths

  • Piotroski F-Score of 8 out of 9: most of the nine accounting health tests pass.
  • Has raised its dividend for 7 years in a row.

Risks and weak spots

  • Fair value vs price is weak against Financials peers (0.3×).
  • The price is above our fair value range, so good news may already be in the price.

Latest SEC filings

DateFormItems
4 Aug 202610-Q
23 Jul 20268-K2.02,9.01
9 Jun 20268-K8.01,9.01
4 Jun 2026424B5
20 May 20268-K5.02,7.01,9.01
7 May 202610-Q
30 Apr 20268-K5.07,9.01
23 Apr 20268-K2.02,9.01

How to read this report

Every number comes from SEC filings, end-of-day prices and the StocksXray models described on the methodology page. The X-Ray Score ranks each metric against the company's own sector. Fair value blends three models and carries a typical error of about 40%, so treat it as a range. Analyst ratings, price targets and earnings-call summaries are not part of this report. Educational research, not financial advice; read the disclaimer.

stocksxray.com · page 5 · generated 19 Oct 2026